You are here: Industry Insights > ANDA

News List

Glenmark receives ANDA approval for Clobetasol Propionate Foam biospectrumasia
February 19, 2019
It is a generic version of Olux®1 Foam, 0.05%, of Mylan Pharmaceuticals
Glenmark receives ANDA approval for sevelamer hydrochloride tablets expressbpd
February 12, 2019
Sevelamer is indicated to patients with severe kidney disease to lower high blood phosphorus levels
Mylan Announces Launch of Generic Lialda americanpharmaceuticalreview
December 19, 2018
Mylan announced the U.S. launch of Mesalamine Delayed-Release Tablets USP, 1.2 g, a generic version of Shire's Lialda Delayed-Release Tablets......
Glenmark Pharmaceuticals receives ANDA approval for Fluocinolone Acetonide Oil expressbpd
December 19, 2018
Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio
Glenmark receives ANDA approval for Hydrocortisone Valerate Ointment expressbpd
December 17, 2018
The company is eligible for 180 days of CGT exclusivity upon commercialisation
With Advair generics looming, GSK sharpens ax for 650 job cuts fiercepharma
December 12, 2018
After a business review unveiled in July—and ahead of new challenges—GlaxoSmithKline is sharpening its jobs ax to cut 650 across its U.S. business.
Cycle Pharmaceuticals Receives FDA Approval for Ketorolac Tromethamine Tablets in the U.S. pharmafocusasia
November 26, 2018
Cycle Pharmaceuticals Ltd (“Cycle”) is pleased to announce that it has received approval from the U.S. Food and Drug Administration (“FDA”) of its Abbreviated New Drug Application (“ANDA”) for...
Lawmakers field bill tying U.S. drug prices to prices abroad fiercepharma
November 26, 2018
Sen. Bernie Sanders, I-Vt., has spent years railing at the pharma industry, touting a series of proposals to control costs—each typically opposed by the industry.
Samsung Bioepis’ biosimilar to Humira launched in the EU pharmaceutical
November 19, 2018
ImraldiHumira, which is admistered by injection, has lost its exclusive patent in the EU, leading to the launch of biosimilars, including Samsung Bioepis' Imraldi. Credit: Pixabay.
Breckenridge Announces Final Approval of its ANDA for Roflumilast Tablets americanpharmaceuticalreview
October 12, 2018
Breckenridge Pharmaceutical announced the U.S. Food and Drug Administration (FDA) has granted final approval for its Abbreviated New Drug Application for Roflumilast Tablets, 500mcg, generic for Daliresp Tablets by AstraZeneca Pharmaceutical. Breckenridge

Previous page 1 2 3 4 5 6 7 Next page